# Rupali S. Avasare

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rupali-s-avasare/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,046 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 23 |
| i10-index | 36 |
| Last Known Institution | Oregon Health & Science University |
| OpenAlex ID | https://openalex.org/A5036736909 |
| ORCID iD | 0000-0001-8432-2186 |
| Works | 64 |

## Researcher papers

- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics](https://scholariq.org/papers/fabrication-and-biocompatibility-of-polypyrrole-implants-suitable-for-neural/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States](https://scholariq.org/papers/characteristics-and-outcomes-of-individuals-with-pre-existing-kidney-disease-and/)
- [C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy](https://scholariq.org/papers/c3-glomerulonephritis-and-dense-deposit-disease-share-a-similar-disease-course/)
- [Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy](https://scholariq.org/papers/results-from-part-a-of-the-multi-center-double-blind-randomized-placebo/)
- [Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19](https://scholariq.org/papers/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic/)
- [Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy](https://scholariq.org/papers/mycophenolate-mofetil-in-combination-with-steroids-for-treatment-of-c3/)
- [Kidney Transplantation in C3 Glomerulopathy: A Case Series](https://scholariq.org/papers/kidney-transplantation-in-c3-glomerulopathy-a-case-series/)
- [Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study](https://scholariq.org/papers/clinical-characteristics-and-treatment-patterns-of-children-and-adults-with-iga/)
- [Management of Lupus Nephritis: New Treatments and Updated Guidelines](https://scholariq.org/papers/management-of-lupus-nephritis-new-treatments-and-updated-guidelines/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Researcher university

- [Oregon Health & Science University](https://scholariq.org/institutions/oregon-health-and-science-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.